⮝ Full datasets listing

PXD066807

PXD066807 is an original dataset announced via ProteomeXchange.

Dataset Summary
TitleHepatocyte-specific Cas9-mediated editing of G6pc and Slc37a4 elicits comparable biochemical and regulatory responses between glycogen storage disease (GSD) type Ia and Ib mice
DescriptionGlycogen storage disease type I (GSD I) is an autosomal recessive inborn error of carbohydrate metabolism. Patients with GSD type Ia and Ib exhibit overlapping and distinct symptoms and complications. Notably, GSD Ia patients show more severe hypertriglyceridemia and higher risk of hepatic tumors than GSD Ib patients. Given the liver's pivotal role in these processes, this study utilized hepatocyte-specific CRISPR/Cas9-mediated gene editing to explore the pathophysiological and biochemical differences between hepatic GSD Ia and Ib. Additionally, hepatic histology, transcriptomics, and proteomics analysis was performed. Compared to controls, GSD Ia and Ib mice showed hepatomegaly, fasting hypoglycemia, hyperlactatemia, and increased uric acid in plasma, which was more pronounced in GSD Ia than Ib. Both GSD I subtypes showed similar reductions in hepatic acetyl-CoA precursor pool enrichment and inceases in de novo biosynthesis of hepatic stearate and oleate. Interestingly, only GSD Ia mice showed significantly elevated plasma triglyceride, uric acid, and hepatic phosphate sugars. These metabolic changes were reflected at the level of transcriptomics and proteomics results. Moreover, altered mRNAs and protein levels related to nucleotide-binding oligomerization domain (NOD) signaling pathways, infection and inflammation, liver disease, and chemical carcinogenesis were more pronounced in GSD Ia mice. Overall, the metabolic disturbance was more severe in hepatocyte-specific GSD Ia than Ib mice, consistent with the clinical phenotype on patients. The metabolic disorders and specific metabolites, genes, and proteins identified in this study provided new insights into the potential therapeutic targets for GSD I patients, highlighting the need for subtype-specific treatment strategies.
HostingRepositoryPRIDE
AnnounceDate2026-07-02
AnnouncementXMLSubmission_2026-07-02_13:58:39.389.xml
DigitalObjectIdentifier
ReviewLevelPeer-reviewed dataset
DatasetOriginOriginal dataset
RepositorySupportUnsupported dataset by repository
PrimarySubmitterJustina Clarinda Wolters
SpeciesList scientific name: Mus musculus (Mouse); NCBI TaxID: NEWT:10090;
ModificationListacetylated residue; monohydroxylated residue; iodoacetamide derivatized residue
InstrumentOrbitrap Exploris 480
Dataset History
RevisionDatetimeStatusChangeLog Entry
02025-07-31 07:46:23ID requested
12026-07-02 13:58:40announced
Publication List
Krishnamurthy KA, Xiao R, Rutten MGS, Bos T, Bleeker A, Zhang M, de Vries HI, Koster M, Huijkman N, Smit M, Kloosterhuis N, Boer T, Schomakers B, van Weeghel M, van de Sluis B, Wolters JC, Bakker BM, Oosterveer MH, Hepatocyte-specific Cas9-mediated editing of G6pc and Slc37a4 elicits comparable biochemical and regulatory responses between glycogen storage disease (GSD) type Ia and Ib mice. Mol Metab, 110():102393(2026) [pubmed]
10.1016/j.molmet.2026.102393;
Keyword List
submitter keyword: mouse, proteomics, liver, GSD I
Contact List
Dr. JC Wolters
contact affiliationLaboratory of Pediatrics, UMCG, The Netherlands
contact emailj.c.wolters@umcg.nl
lab head
Justina Clarinda Wolters
contact affiliationUMCG
contact emailj.c.wolters@umcg.nl
dataset submitter
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/07/PXD066807
PRIDE project URI
Repository Record List
[ + ]